Neogen Corporation

NASDAQ NEOG

Download Data

Neogen Corporation Return on Common Equity 3 year CAGR for the quarter ending May 31, 2023: -54.83%

Neogen Corporation Return on Common Equity 3 year CAGR is -54.83% for the quarter ending May 31, 2023, a -197.02% change year over year. Return on common equity measures the profitability of a company relative to its common shareholders' equity. It is calculated by dividing the net income by the common stock (net). This ratio indicates how effectively a company generates profit for its common shareholders' equity investment. A higher return on common equity suggests better profitability and value creation for common shareholders. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.
  • Neogen Corporation Return on Common Equity for the quarter ending February 28, 2022 was 31.55%, a -79.81% change year over year.
  • Neogen Corporation Return on Common Equity for the quarter ending February 28, 2021 was 156.24%, a 8.42% change year over year.
  • Neogen Corporation Return on Common Equity for the quarter ending February 29, 2020 was 144.11%, a -8.08% change year over year.
NASDAQ: NEOG

Neogen Corporation

CEO Mr. John Edward Adent
IPO Date Aug. 23, 1989
Location United States
Headquarters 620 Lesher Place, Lansing, MI, United States, 48912
Employees 2,640
Sector Healthcare
Industry Diagnostics & research
Description

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared foods and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Similar companies

QGEN

Qiagen NV

NA

NA

OLK

Olink Holding AB ADR

NA

NA

ICLR

ICON PLC

NA

NA

FONR

Fonar Corporation

NA

NA

XGN

Exagen Inc

NA

NA

SERA

Sera Prognostics Inc

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email